Preventing the unfolded protein response via aberrant activation of 4E-binding protein 1 by versipelostatin

Cancer Science

Volumn 100, Issue 2, 2009, Pages 327-333

  Matsuo, Junichi ^a,b   Tsukumo, Yoshinori ^a   Sakurai, Junko ^a   Tsukahara, Satomi ^a   Park, Hae Ryong ^c   Shin Ya, Kazuo ^d   Watanabe, Toshiki ^b   Tsuruo, Takashi ^a   Tomida, Akihiro ^a  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Kyungnam University   (South Korea)

^d NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; GLUCOSE; GLUCOSE REGULATED PROTEIN 78; INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN 1; MACROCYCLIC COMPOUND; RAPAMYCIN; UNCLASSIFIED DRUG; VERSIPELOSTATIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL STRAIN HEK293; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EMBRYO; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN SYNTHESIS; RNA INTERFERENCE;

ACTIVATING TRANSCRIPTION FACTOR 4; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUCIFERASES; MACROLIDES; OLIGOSACCHARIDES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; RNA, SMALL INTERFERING; SIROLIMUS; UNFOLDED PROTEIN RESPONSE;

EID: 58549115710     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2008.01036.x     Document Type: Article

References (35)

1. Brown JM, Giaccia AJ. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res 1998; 58: 1408-16.
2. Scrivaen P, Brown NJ, Pockley AG, Wyld L. The unfolded protein response and cancer: A brighter future unfolding? J Mol Med 2007; 85: 331-41.
3. Zhao L, Ackerman SL. Endoplasmic reticulum stress in health and disease. Curr Opin Cell Biol 2006; 18: 1-9.
4. Ma Y, Hendershot LM. The role of the unfolded protein response in tumor development: Friend or foe? Nat Rev Cancer 2004; 4: 966-77.
5. Lee AS. GRP78 induction in cancer: Therapeutic and prognostic implications. Cancer Res 2007; 67: 3496-9.
6. Lee E, Nichols P, Spicer D, Groshen S, Yu MC, Lee AS. GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer. Cancer Res 2007; 66: 7849-53.
7. Pyrko P, Schonthal AH, Hofman FM, Chen TC, Lee AS. The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res 2007; 67: 9809-16.
8. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007; 8: 519-29.
9. Marciniak SJ, Ron D. Endoplasmic reticulum stress signalling in disease. Physiol Rev 2006; 86: 1133-49.
10. Dong D, Ni M, Li J et al. Critical role in the stress chaperone GRP78/ BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res 2008; 68: 498-505.
11. Bi M, Naczki C, Koritzinsky M et al. ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth. EMBO J 2005; 24: 3470-81.
12. Harding HP, Zhang Y, Bertolotti A, Zeng H, Ron D. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol Cell 2000; 5: 897-04.
13. Marciniak SJ, Yun CY, Oyadomari S et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev 2004; 18: 3066-77.
14. Harding HP, Zhang Y, Ron D. Protein translation and folding are coupled by an endoplasmic reticulum-resident kinase. Nature 1999; 397: 271-4.
15. Harding HP, Novoa I, Zhang Y et al. Regulated translation initiation controls stress-induced gene expression in mammalian cells. Mol Cell 2000; 6: 1099-08.
16. Ma Y, Hendershot LM. Delineation of a negative feedback regulatory loop that controls protein translation during endoplasmic reticulum stress. J Biol Chem 2003; 278: 34 864-73.
17. Kojima E, Takeuchi A, Haneda M et al. The function of GADD34 is a recovery from a shutoff of protein synthesis induced by ER stress-elucidation by GADD34-deficient mice. FASEB J 2003; 17: 1573-5.
18. Novoa I, Zhang Y, Zeng H, Jungreis R, Harding HP, Ron D. Stress-induce gene expression requires programmed recovery from translational repression. EMBO J 2003; 22: 1180-7.
19. Graff JR, Konicek BW, Carter JH, Marcusson EG. Targeting the eukaryotic translation initiation factor 4E for cancer therapy. Cancer Res 2008; 68: 631-4.
20. Polunovsky VA, Bitterman PB. The cap-dependent translation apparatus integrates and amplifies cancer pathway. RNA Biol 2006; 3: 10-17.
21. Dever TE. Gene-specific regulation by general translation factors. Cell 2002; 108: 545-56.
22. Gingras A, Raught B, Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev 2001; 15: 807-26.
23. Gingras A, Gygi SP, Raught B et al. Regulation of 4E-BP1 phosphorylation: A novel two-step mechanism. Genes Dev 1999; 13: 1422-37.
24. Fels DR, Koumenis C. The PERK/eIF2α/ATF4 module of the UPR in hypoxia resistance and tumor growth. Cancer Biol Ther 2006; 5: 723-8.
25. Park H, Tomida A, Sato S et al. Effect on tumor cells of blocking survival response to glucose deprivation. J Natl Cancer Inst 2004; 96: 1300-10.
26. Horie K, Tomida A, Sugimoto Y et al. SUMO-1 conjugation to intact DNA topoisomerase I amplifies cleavable complex formation induced by camptothecin. Oncogene 2002; 21: 7913-22.
27. Polunovsky VA, Gingras A, Sonenberg N et al. Translational control of the antiapoptotic function of Ras. J Biol Chem 2000; 275: 24 776-80.
28. Tsukumo Y, Akihiro T, Kitahara O. Nucleobindin 1 controls the unfolded protein response by inhibiting ATF6 activation. J Biol Chem 2007; 282: 29 264-72.
29. Arsham AM, Howell JJ, Simon MC. A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J Biol Chem 2003; 32: 29 655-60.
30. Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Meth 1986; 89: 271-7.
31. Yamaguchi Y, Ishihara H, Yamada T et al. ATF4-mediated induction of 4E-BP1 contributes to pancreatic β cell survival under endoplasmic reticulum stress. Cell Metab 2008; 7: 269-76.
32. Koritzinsky M, Magagnin MG, Beucken T et al. Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control. EMBO J 2006; 25: 1114-25.
33. Hudes G, Carducci M, Tomczak P et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 2007; 356: 2271-81.
34. Motzer R, Escudier B, Oudard S et al. Efficiency of everolimus in advanced renal cell carcinoma: A double-blind, randomized, placebo-controlled phase III trial. Lancet 2008; 372: 449-56.
35. Gridelli C, Maione P, Rossi A. The potential role of mTOR inhibitors in non-small cell lung cancer. Oncologist 2007; 13: 139-47.